Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177Paul D. Brown, Jan C. Buckner, Sunil Krishnan et al.|Journal of Clinical Oncology|2008Cited by 275
Novel <i>SOX10</i> indel mutations drive schwannomas through impaired transactivation of myelination gene programsErik A. Williams, David A. Solomon, Abigail K. Suwala et al.|Neuro-Oncology|2023Cited by 31